Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jessica Angell

Nurse Practitioner, Adult Health Westlake, OH Nurse Practitioner

NPI 1033407028 CMS profile 10715673

850 Columbia Rd Ste 200, Westlake, OH 44145

Open in the dashboard

General payments

$8,377

279 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Angell of Westlake, OH is reported in the CMS Open Payments database as having received $8,377 across 279 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,759 54
2024 General $3,011 79
2023 General $1,024 65
2022 General $1,052 55
2021 General $532 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Angell
  • Nurse Practitioner, Adult Health median
  • Middle half of Nurse Practitioner, Adult Health
  • National median

In program year 2025, general payments to Jessica Angell were reported at $2,759. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.

Show as a table
Year Jessica Angell Nurse Practitioner, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $532 $138 $43–$438 $132
2022 $1,052 $165 $54–$494 $149
2023 $1,024 $178 $61–$549 $160
2024 $3,011 $186 $62–$575 $164
2025 $2,759 $184 $59–$580 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Genentech USA, Inc. $1,614 4 payments
  2. AbbVie, Inc. $1,504 79 payments
  3. Genentech, Inc. $1,354 4 payments
  4. Janssen Biotech, Inc. $918 37 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $545 31 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $329 19 payments
  7. Genzyme Corporation $260 13 payments
  8. QOL Medical, LLC $203 9 payments
  9. Intercept Pharmaceuticals, Inc. $200 6 payments
  10. Ironwood Pharmaceuticals, Inc $188 6 payments
  11. Other $1,263 71 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,459 274 payments
  2. Travel and Lodging $1,902 4 payments
  3. Education $16 1 payment
Products named General payments · program years 2021–2025
  1. TREMFYA $645 18 payments
  2. RINVOQ $645 42 payments
  3. SKYRIZI Immunology $419 19 payments
  4. ENTYVIO $368 23 payments
  5. LINZESS Gastroenterology $345 19 payments
  6. STELARA $273 19 payments
  7. SKYRIZI Immunology $237 10 payments
  8. DUPIXENT $235 12 payments
  9. CREON $188 15 payments
  10. Linzess Gi $188 6 payments
  11. Other $2,650 138 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

76

Median for Nurse Practitioner: 389

Drug cost

$5,476

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ursodiol Generic 33 $5,035
Pantoprazole Sodium Generic 27 $277
Omeprazole Generic 16 $164

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$974

Medicare's payments for the services billed

Medicare patients

18

Average age 71

Services billed

21

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 28 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LINZESS
  • Ironwood Pharmaceuticals, Inc $115
  • AbbVie, Inc. $50
$165 — —
ENTYVIO
  • Takeda Pharmaceuticals U.S.A., Inc. $126
$126 — —
STELARA
  • Janssen Biotech, Inc. $112
$112 — —
RINVOQ
  • AbbVie, Inc. $111
$111 — —
DUPIXENT
  • GENZYME CORPORATION $74
  • Regeneron Healthcare Solutions, Inc. $22
$97 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 28 with Patron

Records

279 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Adult Health in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record